Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ryanodine receptor 1 (RYR1) is a large intracellular calcium release channel primarily expressed in skeletal muscle. It is a homotetrameric protein complex located on the sarcoplasmic reticulum membrane. RYR1 plays a central role in excitation-contraction coupling by releasing Ca²⁺ from SR stores into the cytoplasm, initiating muscle contraction. Mutations in *RYR1* are associated with malignant hyperthermia susceptibility and central core disease, among other congenital myopathies.
Ryanodine receptors are intracellular calcium channels that mediate the release of calcium from intracellular stores. Drugs can either activate or inhibit the channel, leading to altered calcium homeostasis in cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ryanodine receptor 1 (RYR1).